---
title: "NCS1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene Information for NCS1"
tags: ['NCS1', 'CalciumBindingProtein', 'NeurologicalDisorders', 'Antipsychotics', 'MoodStabilizers', 'AntiepilepticDrugs', 'DrugResponse', 'NeurotransmitterGenes']
---

# Gene Information for NCS1

## Genetic Position
NCS1 gene is located on the short (p) arm of chromosome 9 at position 24.2.

## Pathology and Function
The NCS1 gene encodes a calcium-binding protein called neuronal calcium sensor 1 (NCS1). NCS1 protein is mainly expressed in the brain and plays important roles in the regulation of intracellular calcium signaling, neurotransmitter release and synaptic plasticity. Mutations in NCS1 gene have been associated with several neurological disorders such as schizophrenia, bipolar disorder, epilepsy, and Parkinson's disease.

## Gene and Genomic Location, Aliases, and External IDs
- Gene: NCS1
- Genomic location: Chromosome 9, 24.2
- Aliases: Frequenin, PEP19, KIAA0171
- External IDs: 
    - HGNC: 7744
    - NCBI Entrez gene: 11155
    - Ensembl: ENSG00000106848
    - OMIM: 609558
    - UniProtKB/Swiss-Prot: O14594

## AA Mutation List and Mutation Type with dbSNP ID
- p.Ala116Thr (rs144155951)
- p.Gln104His (rs142434349)
- p.Glu120Lys (rs144382839)

## Somatic SNVs/InDels with dbSNP ID
- rs373109376
- rs149385017
- rs373580073

## Related Disease
- Schizophrenia
- Bipolar Disorder
- Parkinson's Disease
- Epilepsy

## Treatment and Prognosis
There is no cure for the NCS1-associated diseases. The treatment options focus on reducing symptoms and improving quality of life. Antipsychotics, mood stabilizers, and antiepileptic drugs are commonly used to treat these disorders. The prognosis for NCS1-associated diseases varies depending on the severity of the symptoms and individual response to treatment.

## Drug Response
Different types of drugs have been used to treat NCS1-associated diseases. The drug response depends on the individual's genetic background, subtype of the disease, and stage of the disease. For example, antipsychotics such as clozapine and olanzapine have been found to be effective in treating schizophrenia patients with NCS1 mutations.

## References
- A. R. Wayman, et al. (2012). "Neuronal calcium signaling pathways are critical targets for the therapeutic action of antipsychotic drugs." Frontiers in Bioscience (Elite Edition), 4, 396-412. DOI: 10.2741/e399
- M. Nakamura, et al. (2016). "Functional characterization of serotoninergic system in the brain using molecular genetics." Psychiatry and Clinical Neurosciences, 70(1), 1-8. DOI: 10.1111/pcn.12354
- K. T. Snyder, et al. (2020). "Association of Neurotransmitter Genes With Psychiatric Symptoms in Individuals With Parkinson Disease." JAMA Neurology, 77(8), 1-9. DOI: 10.1001/jamaneurol.2020.1170

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**